Open Targets From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. March is time for E.
Open Targets Platform Open Targets Platform: release 19.02 is out Our latest release of the Open Targets Platform is out. We have more targets, more diseases, more evidence, more associations, and fixed some bugs too.
Open Targets Looking for cell line models to predict drug response in cancer patients? On this World Cancer Day, Hanna writes about Cellector, an open source tool for the selection of clinically relevant cancer cell lines for in vitro experiments.
Open Targets Platform From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. It's D-time.
Open Targets Platform Open Targets Platform: release 18.12 is out Our latest release of the Open Targets Platform is out. New data source - systems biology, new target tractability visualisation and more non-coding RNA genes.
Open Targets Platform From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. Third in the series is C.
Open Targets Platform How to add a new data source to the Open Targets Platform, part 2 In this post, I will continue guiding you on how to add a new data source to the Open Targets Platform. This is part 2 of a 2-part series of posts.
genetic associations How to add a new data source to the Open Targets Platform - part 1 I have recently been working on a project for Genomics England that involved adding a new data source to the Open Targets Platform. This two-part series of blog posts describes my experience, with
Open Targets Platform How to navigate the complexity of cancer genetics with the Cancer Gene Census Cancer is not a single disease, but a group of diseases underlined by extraordinary genetic complexity. How can cancer researchers navigate this complexity?
Open Targets From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. Second in the series is B.
release notes Open Targets Platform: what's new in our latest release Our latest release of the Open Targets Platform is out. More targets, more evidence, more target-disease associations and a new prioritisation view.
Open Targets From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the lexicon of terms that matter to Open Targets. First in the series is A.
chemical probes Probing your next target? Use our Chemical Probes feature for target validation in Open Targets Chemical probes are powerful research reagents for preclinical target validation in drug development projects.
Open Targets Platform Open Targets Platform: new release is out The latest release of the Open Targets Platform is out. We have more evidence, new targets, new diseases and new associations, plus data from Probe Miner.
Open Targets Platform Get to know the Reactome enhanced pathway visualisations Open Targets Q&A on the new Reactome pathway visualisations: scalable, interactive textbook-style diagrams in SVG format, freely downloadable and editable.
Open Targets Platform Open Targets meets Docker and Luigi In the latest release of our Open Targets Platform, we have 18 publicly available data sources all integrated in one place to facilitate your drug target identification and prioritisation. We process this data
Open Targets Platform We have a new release of the Open Targets Platform The latest version of the Open Targets Platform is out. Why not check the new target-disease associations and the new chemical probes we have to offer?
Open Targets Platform Everything you need to know about the new GWAS Catalog Open Targets is investing in a new project to expand the scope of the GWAS Catalog to include targeted arrays, such as MetaboChip and ImmunoChip.
Europe PMC How Europe PMC can help you find associations between genes and diseases Open Targets Q&A on how you can stay up-to-date with the latest advances in drug discovery.
release notes The latest release of the Open Targets Platform is out! We have a new release of the Open Targets Platform. New data source for target-disease associations, new drug visualisations, cancer biomarkers, and more.
Open Targets Touring with Takeda Following Takeda joining Open Targets in December 2017, I set off to Takeda in the US and Japan for a series of workshops.
Open Targets Open Targets Platform: we have a new release The latest release of Open Targets Platform is out. We now have the cancer hallmarks, targeted association studies, a YouTube channel and much more.
Open Targets How to predict the success of drug development If you are attending BioData World West 2018 in San Francisco, come one day earlier and join our training sessions, a workshop and a datathon.
plugins The plugin architecture of the Open Targets Platform In computing, a plugin is a component that extends the functionality of an existing computer program. But how is it used on the Open Target Platform?
Open Targets How CRISPR will guide the way to better cancer therapies Fiona Behan tells us why she works in cancer research with Open Targets and how CRISPR/Cas9 has revolutionised the fight against cancer.
